Clear Street
4 World Trade Center, 150 Greenwich Street, 45th Floor, New York, NY, 10007, United States
Overview
Clear Street is modernizing the brokerage ecosystem. Founded in 2018, Clear Street is a diversified financial services firm replacing the legacy infrastructure used across capital markets. The firm started from scratch by building a completely cloud-native clearing and custody system designed for today’s complex, global market. Clear Street’s proprietary platform adds significant efficiency to the market while focusing on minimizing risk, redundancy, and cost for clients. Clear Street’s goal is to create a single platform for every asset class, in every country, and in any currency.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 2
- Active investors
- 8
Sector focus
- Cloud Infrastructure
- Financial Services
- FinTech
Investment portfolio
- HavocAI
Participated · Series A · May 2026
Havoc develops an all-domain collaborative autonomy stack and a software-defined hardware approach that enables heterogeneous autonomous assets to sense, decide, and act together across sea, air, and land. The company reports more than 25,000 hours of autonomous testing and deployments and has collected over 200 billion data points from operations to iterate its field-tested autonomy stack. Havoc has built and deployed 100+ autonomous surface vessels (ASVs) globally, with 40+ mission-ready today and 30+ vessels delivered to the U.S. Department of Defense. It has made strategic acquisitions (Mavrik and Teleo) to expand into air and land domains and maintains partnerships with defense primes such as Leidos, Lockheed Martin, and SAIC as well as shipbuilders and additive manufacturers. Havoc has grown to over 200 employees, opened new offices in Austin and San Diego, and expanded maritime production in Rhode Island. The company highlights award recognition, SBIR awards, and selection to industry challenges as validation while positioning itself to scale deployments and production to meet defense and commercial demand.
- Tharimmune
Participated · Equity · Nov 2025
Tharimmune Inc. develops clinical-stage biotechnology assets while simultaneously executing a new digital-asset treasury strategy. The company plans to purchase Canton Coin, the utility token of the Canton Network, and run a Super Validator node on that blockchain to earn additional tokens. To lead this initiative, Tharimmune appointed Mark Wendland as chief executive officer and Mark Toomey as president, while its existing team continues to advance the firm’s biotech pipeline. Canton Network, which connects major financial institutions such as Goldman Sachs, DTCC, and BNP Paribas, recorded more than 500,000 daily transactions as of 30 September 2025, underscoring the scale of the ecosystem Tharimmune is entering. The $540 million capital raise gives the company significant resources for both token acquisition and general working capital. Shares in the financing were priced at $3.075 each. The securities were sold to accredited institutional investors under Section 4(a)(2) of the Securities Act and were not registered with the SEC.